Dr Hatankar'S Scientific Ayurveda Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 19 Year, 27 Days
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 43.69%
- Profit Growth -18.70%
- Ebitda -25.12%
- Net Worth 21.62%
- Total Assets -31.68%
About Dr Hatankar'S Scientific Ayurveda
Dr Hatankar's Scientific Ayurveda Private Limited (DHSAPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 January 2006 and has a history of 19 years. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Snehal Hatankar and Vijay Hatankar serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24233PN2006PTC021774
- Company No.
021774
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jan 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Dr Hatankar'S Scientific Ayurveda?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Snehal Hatankar  | Director | 03-Jan-2006 | Current |
| Vijay Hatankar | Director | 03-Jan-2006 | Current |
Financial Performance of Dr Hatankar'S Scientific Ayurveda.
Dr Hatankar'S Scientific Ayurveda Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 43.69% increase. The company also saw a substantial fall in profitability, with a 18.7% decrease in profit. The company's net worth Soared by an impressive increase of 21.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr Hatankar'S Scientific Ayurveda?
In 2019, Dr Hatankar'S Scientific Ayurveda had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dr Hatankar'S Scientific Ayurveda?
Unlock and access historical data on people associated with Dr Hatankar'S Scientific Ayurveda, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr Hatankar'S Scientific Ayurveda, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr Hatankar'S Scientific Ayurveda's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.